192 related articles for article (PubMed ID: 15167059)
41. [Backache as the initial symptom of adrenomyeloneuropathy].
Benito-León J; Zamorano T; Martín-Peña G; Tapia MA; Alvarez-Linera J
Rev Neurol; 2000 Dec 16-31; 31(12):1167-70. PubMed ID: 11205553
[TBL] [Abstract][Full Text] [Related]
42. Dietary management of X-linked adrenoleukodystrophy.
Moser HW; Borel J
Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
[TBL] [Abstract][Full Text] [Related]
43. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
Zinkham WH; Kickler T; Borel J; Moser HW
N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
[No Abstract] [Full Text] [Related]
44. The X-linked adrenoleukodystrophy (X-ALD) and oxidative stress.
Al-Omar MA
J Herb Pharmacother; 2006; 6(3-4):125-34. PubMed ID: 17317654
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of Lorenzo oil in adrenomyeloneuropathy.
Simon E
Ann Neurol; 1994 Jul; 36(1):116-7. PubMed ID: 8024253
[No Abstract] [Full Text] [Related]
46. A happier sequel to Lorenzo's Oil?
Wanders RJ
Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
[No Abstract] [Full Text] [Related]
47. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.
Loes DJ; Fatemi A; Melhem ER; Gupte N; Bezman L; Moser HW; Raymond GV
Neurology; 2003 Aug; 61(3):369-74. PubMed ID: 12913200
[TBL] [Abstract][Full Text] [Related]
48. [X-linked adrenoleukodystrophy (ALD)].
Imamura A; Suzuki Y
Nihon Rinsho; 2004 Jan; 62 Suppl():389-92. PubMed ID: 15011392
[No Abstract] [Full Text] [Related]
49. Lorenzo's oil: a reassessment.
Poulos A; Robertson EF
Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
[No Abstract] [Full Text] [Related]
50. More on Lorenzo's oil.
Odone A; Odone M
N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
[No Abstract] [Full Text] [Related]
51. Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.
Berger J; Pujol A; Aubourg P; Forss-Petter S
Brain Pathol; 2010 Jul; 20(4):845-56. PubMed ID: 20626746
[TBL] [Abstract][Full Text] [Related]
52. [Adrenoleukodystrophy, adrenomyeloneuropathy].
Yorifuji T
Nihon Rinsho; 2006 May; Suppl 1():582-5. PubMed ID: 16776221
[No Abstract] [Full Text] [Related]
53. Adrenoleukodystrophy.
Moser HW
Curr Opin Neurol; 1995 Jun; 8(3):221-6. PubMed ID: 7551122
[TBL] [Abstract][Full Text] [Related]
54. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP
J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896
[TBL] [Abstract][Full Text] [Related]
55. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.
Moser HW; Powers JM; Smith KD
Brain Pathol; 1995 Jul; 5(3):259-66. PubMed ID: 8520725
[TBL] [Abstract][Full Text] [Related]
56. Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
Sedlmayr P; Plecko B; Paschke E; Zenz W; Ramschak H; Toplak H; Wascher TC; Wilders-Truschnig M; Stöckler S
J Inherit Metab Dis; 1995; 18(1):101-2. PubMed ID: 7623436
[No Abstract] [Full Text] [Related]
57. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter.
Tourbah A; Stievenart JL; Iba-Zizen MT; Lubetzki C; Baumann N; Eymard B; Moser HW; Lyon-Caen O; Cabanis EA
Arch Neurol; 1997 May; 54(5):586-92. PubMed ID: 9152115
[TBL] [Abstract][Full Text] [Related]
58. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.
Cappa M; Bizzarri C; Petroni A; Carta G; Cordeddu L; Valeriani M; Vollono C; De Pasquale L; Blasevich M; Banni S
J Inherit Metab Dis; 2012 Sep; 35(5):899-907. PubMed ID: 22189598
[TBL] [Abstract][Full Text] [Related]
59. Temporary improvement of neurological symptoms with gammaglobulin therapy in a boy with adrenoleukodystrophy.
Oka A; Saito M; Kubota M; Sakakihara Y; Yanagisawa M
Brain Dev; 1996; 18(2):119-21. PubMed ID: 8733902
[TBL] [Abstract][Full Text] [Related]
60. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
